Article Information
PubMed
Published By
Print ISSN
Online ISSN
Copyright & Usage
COPYRIGHT© 1999 by the Society of Nuclear Medicine, Inc.
Author Information
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Complementary, Selective PET Imaging of Integrin Subtypes {alpha}5{beta}1 and {alpha}v{beta}3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin
- 99mTc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study
- Effects of Photoacoustic Imaging and Photothermal Ablation Therapy Mediated by Targeted Hollow Gold Nanospheres in an Orthotopic Mouse Xenograft Model of Glioma
- Fluorescence Reflectance Imaging of Macrophage-Rich Atherosclerotic Plaques Using an {alpha}v{beta}3 Integrin-Targeted Fluorochrome
- Radionuclide Imaging: A Molecular Key to the Atherosclerotic Plaque
- Preparation of a Promising Angiogenesis PET Imaging Agent: 68Ga-Labeled c(RGDyK)-Isothiocyanatobenzyl-1,4,7-Triazacyclononane-1,4,7-Triacetic Acid and Feasibility Studies in Mice
- Correlative Imaging of Hypoxia and Angiogenesis in Oncology
- Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography
- Integrin {alpha}V{beta}3 Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor
- Noninvasive Imaging of Osteoclasts in Parathyroid Hormone-Induced Osteolysis Using a 64Cu-Labeled RGD Peptide
- Favorable Biokinetic and Tumor-Targeting Properties of 99mTc-Labeled Glucosamino RGD and Effect of Paclitaxel Therapy
- How molecular imaging is speeding up antiangiogenic drug development
- In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin {alpha}v{beta}3
- Positron Emission Tomography As an Imaging Biomarker
- PET-Based Human Dosimetry of 18F-Galacto-RGD, a New Radiotracer for Imaging {alpha}v{beta}3 Expression
- Quantitative PET Imaging of Tumor Integrin {alpha}v{beta}3 Expression with 18F-FRGD2
- Molecular Targeting with Peptides or Peptide-Polymer Conjugates: Just a Question of Size?
- Targeting Tumor Angiogenesis: Comparison of Peptide and Polymer-Peptide Conjugates
- Radiolabeled RGD Uptake and {alpha}v Integrin Expression Is Enhanced in Ischemic Murine Hindlimbs
- Radiolabeled RGD Peptides Move Beyond Cancer: PET Imaging of Delayed-Type Hypersensitivity Reaction
- Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides
- Detection of Injury-Induced Vascular Remodeling by Targeting Activated {alpha}v{beta}3 Integrin In Vivo
- Oncological molecular imaging: nuclear medicine techniques
- Signaling through JAM-1 and {alpha}v{beta}3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and {alpha}v{beta}3 complex
- Tumor Targeting with Radiolabeled {alpha}v{beta}3 Integrin Binding Peptides in a Nude Mouse Model
- Arginine-Glycine-Aspartic Acid (RGD)-Peptide Binds to Both Tumor and Tumor-Endothelial Cells in Vivo
- Mechanisms and Future Directions for Angiogenesis-Based Cancer Therapies
- Cilengitide Targeting of {alpha}v{beta}3 Integrin Receptor Synergizes with Radioimmunotherapy to Increase Efficacy and Apoptosis in Breast Cancer Xenografts
- Noninvasive Imaging of {{alpha}}v{beta}3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography
- Glycosylated RGD-Containing Peptides: Tracer for Tumor Targeting and Angiogenesis Imaging with Improved Biokinetics